$1.55
0.00% yesterday
Nasdaq, Aug 11, 10:00 pm CET
ISIN
US7458481014
Symbol
LUNG

ProLung Inc Target price 2025 - Analyst rating & recommendation

ProLung Inc Classifications & Recommendation:

Buy
75%
Hold
25%

ProLung Inc Price Target

Target Price $5.61
Price $1.55
Potential
Number of Estimates 8
8 Analysts have issued a price target ProLung Inc 2026 . The average ProLung Inc target price is $5.61. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 12 analysts: 9 Analysts recommend ProLung Inc to buy, 3 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the ProLung Inc stock has an average upside potential 2026 of . Most analysts recommend the ProLung Inc stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 83.79 98.80
22.00% 17.92%
EBITDA Margin -65.06% -39.30%
26.01% 39.59%
Net Margin -67.30% -64.41%
24.03% 4.29%

8 Analysts have issued a sales forecast ProLung Inc 2025 . The average ProLung Inc sales estimate is

$98.8m
Unlock
. This is
9.11% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$102m 12.92%
Unlock
, the lowest is
$93.6m 3.36%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $83.8m 22.00%
2025
$98.8m 17.92%
Unlock
2026
$117m 18.56%
Unlock
2027
$147m 25.85%
Unlock
2028
$200m 35.69%
Unlock
2029
$338m 69.05%
Unlock
2030
$450m 33.00%
Unlock
2031
$760m 69.08%
Unlock
2032
$882m 16.02%
Unlock

7 Analysts have issued an ProLung Inc EBITDA forecast 2025. The average ProLung Inc EBITDA estimate is

$-38.8m
Unlock
. This is
30.25% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-38.5m 30.78%
Unlock
, the lowest is
$-38.8m 30.29%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $-54.5m 9.74%
2025
$-38.8m 28.77%
Unlock
2026
$-33.8m 13.00%
Unlock
2027
$-20.0m 40.74%
Unlock
2028
$-37.4m 87.00%
Unlock
2029
$15.5m 141.41%
Unlock

EBITDA Margin

2024 -65.06% 26.01%
2025
-39.30% 39.59%
Unlock
2026
-28.84% 26.62%
Unlock
2027
-13.58% 52.91%
Unlock
2028
-18.71% 37.78%
Unlock

9 ProLung Inc Analysts have issued a net profit forecast 2025. The average ProLung Inc net profit estimate is

$-63.6m
Unlock
. This is
11.75% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-63.1m 10.78%
Unlock
, the lowest is
$-63.7m 11.78%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-56.4m 7.31%
2025
$-63.6m 12.84%
Unlock
2026
$-58.7m 7.78%
Unlock
2027
$-49.1m 16.29%
Unlock
2028
$-3.3m 93.24%
Unlock
2029
$89.8m 2,803.61%
Unlock
2030
$150m 66.90%
Unlock
2031
$356m 137.44%
Unlock
2032
$401m 12.73%
Unlock

Net Margin

2024 -67.30% 24.03%
2025
-64.41% 4.29%
Unlock
2026
-50.10% 22.22%
Unlock
2027
-33.32% 33.49%
Unlock
2028
-1.66% 95.02%
Unlock
2029
26.54% 1,698.80%
Unlock
2030
33.31% 25.51%
Unlock
2031
46.78% 40.44%
Unlock
2032
45.45% 2.84%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ -1.44 -1.56
10.00% 8.33%
P/E negative
EV/Sales 0.16

9 Analysts have issued a ProLung Inc forecast for earnings per share. The average ProLung Inc EPS is

$-1.56
Unlock
. This is
11.43% lower
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$-1.56 11.43%
Unlock
, the lowest is
$-1.55 10.71%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-1.44 10.00%
2025
$-1.56 8.33%
Unlock
2026
$-1.44 7.69%
Unlock
2027
$-1.21 15.97%
Unlock
2028
$-0.08 93.39%
Unlock
2029
$2.20 2,850.00%
Unlock
2030
$3.68 67.27%
Unlock
2031
$8.73 137.23%
Unlock
2032
$9.84 12.71%
Unlock

P/E ratio

Current -1.11 70.29%
2025
-0.99 10.58%
Unlock
2026
-1.08 9.09%
Unlock
2027
-1.29 19.44%
Unlock
2028
-19.00 1,372.87%
Unlock
2029
0.70 103.68%
Unlock
2030
0.42 40.00%
Unlock
2031
0.18 57.14%
Unlock
2032
0.16 11.11%
Unlock

Based on analysts' sales estimates for 2025, the ProLung Inc stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.18 90.27%
2025
0.16 9.78%
Unlock
2026
0.14 15.64%
Unlock
2027
0.11 20.51%
Unlock
2028
0.08 26.35%
Unlock
2029
0.05 40.77%
Unlock
2030
0.04 24.84%
Unlock
2031
0.02 40.90%
Unlock
2032
0.02 13.74%
Unlock

P/S ratio

Current 0.70 75.59%
2025
0.64 8.34%
Unlock
2026
0.54 15.66%
Unlock
2027
0.43 20.55%
Unlock
2028
0.32 26.31%
Unlock
2029
0.19 40.83%
Unlock
2030
0.14 24.84%
Unlock
2031
0.08 40.81%
Unlock
2032
0.07 13.84%
Unlock

Current ProLung Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Wells Fargo
Locked
Locked
Locked Aug 01 2025
D. Boral Capital
Locked
Locked
Locked Jul 31 2025
Lake Street
Locked
Locked
Locked Jul 31 2025
Piper Sandler
Locked
Locked
Locked Jul 31 2025
Stifel
Locked
Locked
Locked Jul 31 2025
Citigroup
Locked
Locked
Locked May 22 2025
Canaccord Genuity
Locked
Locked
Locked May 01 2025
Analyst Rating Date
Locked
Wells Fargo:
Locked
Locked
Aug 01 2025
Locked
D. Boral Capital:
Locked
Locked
Jul 31 2025
Locked
Lake Street:
Locked
Locked
Jul 31 2025
Locked
Piper Sandler:
Locked
Locked
Jul 31 2025
Locked
Stifel:
Locked
Locked
Jul 31 2025
Locked
Citigroup:
Locked
Locked
May 22 2025
Locked
Canaccord Genuity:
Locked
Locked
May 01 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today